All Chikungunya virus articles
-
NewsDebilitating virus can spread in cool weather, increasing health risk in Europe
Chikungunya virus, a debilitating tropical disease caused by infected mosquito bites, poses a greater health threat in Europe than previously thought because it can be spread when air temperatures are as low as 13 degrees Celsius.
-
NewsValneva provides update on recommendations for use of IXCHIQ® in UK
Valneva SE has announced that following a review of the benefits and risks of the Company’s single-dose chikungunya vaccine, IXCHIQ® , the United Kingdom’s (UK) Commission on Human Medicines (CHM) has updated its recommendations for use of the vaccine.
-
NewsResearchers on the cusp of a vaccine for a global health threat
Researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. The team tested whether they could engineer E. coli to assemble biopolymer particles which displayed chikungunya antigens and performed as a vaccine.
-
NewsIn rare cases, autoantibodies can cause severe reactions to a live-attenuated virus Chikungunya vaccine that has been discontinued in the U.S.
A new study shows that preexisting autoantibodies in a small subset of the population can allow weakened vaccine viruses to escape control, explaining some adverse events tied to one kind of Chikungunya vaccine, which is no longer available in the U.S.
-
CareersThe National Collection of Pathogenic Viruses (NCPV): a critical resource for virology and public health
It’s now 25 years since the National Collection of Pathogenic Viruses (NCPV) was founded as a dedicated, secure, and relevant national virus repository for the UK. Jane Burton, Teresa Ramalho and Tilly Maybery explore how the collection has evolved - and is tackling future global health concerns.
-
NewsValneva provides update on Chikungunya vaccine IXCHIQ®
Valneva SE has announced that the company has decided to voluntarily withdraw the biologics license application (BLA) and Investigational New Drug (IND) application for its chikungunya vaccine, IXCHIQ® , in the United States, following suspension of the license by the FDA.
-
NewsMosquito saliva may hold clues to fighting chikungunya inflammation
Scientists have uncovered a surprising mechanism showing how mosquito saliva can alter the human body’s immune response during chikungunya virus (CHIKV) infection - it not only transmits the virus but also influences how the body’s immune system responds.
-
NewsResearchers deconstruct chikungunya outbreaks to improve prediction and vaccine development
Researchers analyzed more than 80 outbreaks of chikungunya virus to improve prediction of future outbreaks and inform vaccine trial development.
-
NewsIndia could bear biggest impact from chikungunya, new maps suggest
Based on existing evidence of chikungunya transmission, an infectious disease model predicts 14.4 million people could be at risk of infections globally each year, with 5.1 million people at risk in India.
-
NewsHeadspace invaders: How mosquito-borne viruses breach the brain’s defenses
Using a stem cell-based model of the human blood-brain barrier, researchers compared two closely related Sindbis virus strains — one brain-invading and one not — and found that small changes in viral surface proteins called glycoproteins dictate whether the virus can cross.
-
NewsPediatric investigation study re-examines chikungunya in neglected pediatric victims
Researchers and policymakers must recalibrate their outlook on pediatric chikungunya to develop effective control measures, a new paper warns.
-
NewsT cells take aim at Chikungunya virus
A new study offers the first-ever map of which parts of Chikungunya virus trigger the strongest response from the body’s T cells, bringing researchers closer to developing Chikungunya vaccines or therapies that harness T cells to strike specific targets to halt infection.
-
NewsNew ECDC weekly reports and guidance to tackle mosquito-borne diseases across Europe
As Europe enters this year’s mosquito season, ECDC has launched a new series of weekly epidemiological surveillance updates and public health guidance on mosquito-borne diseases.
-
OpinionReproductive biology though the lens of the microbiome
Madangchanok Imchen and Seth R. Bordenstein from the One Health Microbiome Center - winner of AMI’s WH Pierce Prize 2024 - explore the potential of the reproductive microbiome, particularly the fascinating Wolbachia, to counter global disease threats.
-
NewsValneva reports high sustained immune response in adolescents one year after Chikungunya Vaccine
Valneva SE, a specialty vaccine company, has reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ®, which showed a sustained 98.3% sero-response rate one-year after single vaccination.
-
NewsEl Niño increases infestations of mosquito that transmits dengue in São Paulo state, Brazil
A study by a group of scientists shows that larval infestations of Aedes aegypti in open-air disused containers increased in response to the effects of the weather phenomenon.
-
NewsWHO launches global strategic plan to fight rising Aedes-borne arboviral diseases
The World Health Organization (WHO) has launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP) to tackle dengue and other Aedes-borne arboviruses.
-
NewsScientists awarded $90m to prep for future pandemics from understudied viruses
Scientists are laying the groundwork to rapidly respond to potential future pandemics caused by viruses from five understudied families, developing strategies and tools to produce vaccines and antibody-based therapies.
-
NewsMayaro and chikungunya viruses observed circulating at the same time in the Brazilian Amazon
Infection by one virus was expected to afford protection against the other, preventing co-circulation. Researchers are warning of the risk of transmission of Mayaro in urban areas due to deforestation and advocate more effective epidemiological surveillance.
-
NewsOlympics: how many days does it take for mosquitoes in Greater Paris to transmit arboviruses?
In the run-up to the Olympic Games, scientists have demonstrated that the tiger mosquito, now present in Greater Paris, is capable of transmitting five viruses - West Nile, chikungunya, Usutu, Zika and dengue - within different time frames.